Introduction & Context
Syphilis rose double digits last year; losing national lab capacity widens detection gaps.
Background & History
The Atlanta lab opened in the 1980s, providing centralized sequencing for resistant STIs.
Key Stakeholders & Perspectives
CDC calls the cut shortsighted; budget hawks claim duplication; patient advocates fear rising inequities.
Analysis & Implications
Without centralized data, resistant strains may spread longer, raising costs and fertility risks.
Looking Ahead
Bipartisan lawmakers hint at restoring funds in upcoming appropriations; watch tele-health platforms push at-home STI kits meanwhile.